FDA revises action on compounded ibuprofen, citing oral version shortage
The FDA put out guidance Thursday expanding supply of a specific form of ibuprofen, one of the major active ingredients in over-the-counter pain relief medicine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
